← Leaderboards
Christina Maria Pabelick
Mayo Clinic Rochester
$5,073,168
Attributed
$8,197,809
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,197,809 · 6
By mechanism
R01$7,757,046 · 5
T32$440,763 · 1
Top collaborators
- Y. S. Prakash7 shared
- Denise Al-Alam2 shared
- Peter Macfarlane1 shared
- Daniel J. Tschumperlin1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Y. S. Prakash$21,810,527
- Sathish Venkatachalem$7,099,509
- Paul D. Robbins$18,718,334
- Sundeep Khosla$91,221,003
- Stephen B Kritchevsky$48,894,177
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsResponseLungSignal TransductionInflammatoryAsthmaAirway HyperresponsivenessIn VitroMouse ModelRespiratory Smooth MuscleRegulationAffectStructureBiochemicalAgonistMediatingCell MembraneSmall Interfering RnaSmooth Muscle MyocytesInflammationMethacholineCytokineIn VivoClinically Relevant
Grant awards (18)
Adverse Effects of Neonatal CPAP on Lung Development$740,196
R01 · FY2025 · HL
Cellular Senescence in Trisomy 21 lung disease$610,424
R01 · FY2025 · HL
Hydrogen Sulfide in Neonatal Airway Disease$596,428
R01 · FY2025 · HL · contact PI
Translational Training in Respiratory Disease and Repair$440,763
T32 · FY2025 · HL
Cellular Senescence in Trisomy 21 lung disease$625,799
R01 · FY2024 · HL
Hydrogen Sulfide in Neonatal Airway Disease$584,498
R01 · FY2024 · HL · contact PI
Hydrogen Sulfide in Neonatal Airway Disease$611,178
R01 · FY2023 · HL · contact PI
Nicotine, Airway Smooth Muscle and Asthma$509,999
R01 · FY2022 · HL · contact PI
Nicotine, Airway Smooth Muscle and Asthma$509,999
R01 · FY2021 · HL · contact PI
Nicotine, Airway Smooth Muscle and Asthma$509,999
R01 · FY2020 · HL · contact PI
Nicotine, Airway Smooth Muscle and Asthma$509,999
R01 · FY2019 · HL · contact PI
The Role of Caveolins in Lung Inflammation$320,420
R01 · FY2013 · HL · contact PI
The Role of Caveolins in Lung Inflammation$336,575
R01 · FY2012 · HL · contact PI
The Role of Caveolins in Lung Inflammation$339,975
R01 · FY2011 · HL · contact PI
The Role of Caveolins in Lung Inflammation$339,975
R01 · FY2010 · HL · contact PI
The Role of Caveolins in Lung Inflammation$339,975
R01 · FY2009 · HL · contact PI
The Role of Caveolins in Lung Inflammation$255,711
R01 · FY2009 · HL · contact PI
The Role of Caveolins in Lung Inflammation$15,896
R01 · FY2009 · HL · contact PI